Using multiplex IHC, the authors found that a significant decrease of proliferating Ki67+CD3+CD8− T cells was observed in the tumor stroma after cisplatin and paclitaxel treatment, with increased rates of cytotoxic CD8+ T cells, including activated CD8+Tbet+ T cells. This evidence concerns the gene CD8A and neoplasm.